希玛医疗控股有限公司（股份代号：03309）于2025年12月18日发布翌日披露报表，公告公司在市场上回购股份。根据公告，回购股份数量为320,000股，占回购前公司已发行股本约0.0259%，回购价格区间介乎每股港币1.58元至1.63元，涉资总额约港币517,760元。
本次回购完成后，公司已发行股份总数为1,213,942,870股，库存股份数增至18,400,000股，合计维持在1,232,342,870股。本次回购依据2025年5月19日通过的购回授权进行，授权购回股份总数为125,556,087股，目前公司已回购320,000股，占授权时已发行股数约0.0255%。
公司于公告中确认，已遵守香港联合交易所有限公司证券上市规则的相关规定。公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.